Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Capital Expenditures: 2018-2019

Historic Capital Expenditures for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2019 value amounting to $14,000.

  • DiaMedica Therapeutics' Capital Expenditures rose 207.69% to $14,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $32,000, marking a year-over-year decrease of 36.00%. This contributed to the annual value of $25,000 for FY2024, which is 4.17% up from last year.
  • As of Q4 2019, DiaMedica Therapeutics' Capital Expenditures stood at $14,000, which was up 207.69% from -$13,000 recorded in Q4 2018.
  • In the past 5 years, DiaMedica Therapeutics' Capital Expenditures ranged from a high of $32,000 in Q1 2018 and a low of -$13,000 during Q4 2018.
  • In the last 2 years, DiaMedica Therapeutics' Capital Expenditures had a median value of $14,000 in 2019 and averaged $12,800.
  • Data for DiaMedica Therapeutics' Capital Expenditures shows a peak YoY surged of 207.69% (in 2019) over the last 5 years.
  • Over the past 2 years, DiaMedica Therapeutics' Capital Expenditures (Quarterly) stood at -$13,000 in 2018, then soared by 207.69% to $14,000 in 2019.
  • Its last three reported values are $14,000 in Q4 2019, -$13,000 for Q4 2018, and $21,000 during Q3 2018.